Ir
Ordenar por:
títulofecha de envíofecha de publicación
Orden:
ascendentedescendente
Resultados:
51020406080100
Modificar
Mostrando ítems 1-5 de 5
Immunotherapy in NSCLC patients with brain metastases. Understanding brain tumor microenvironment and dissecting outcomes from immune checkpoint blockade in the clinic [Pre-print]
preprint
Midkine rewires the melanoma microenvironment toward a tolerogenic and immune-resistant state.
journal article
NASH limits anti-tumour surveillance in immunotherapy-treated HCC.
PD-L1ATTAC mice reveal the potential of depleting PD-L1 expressing cells in cancer therapy.
Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1-Selected Advanced Non-Small-Cell Lung Cancer (BIRCH)